Acute myocardial infarction therapy using calycosin and tanshinone co-loaded; mitochondrion-targeted tetrapeptide and cyclic arginyl-glycyl-aspartic acid peptide co-modified lipid-polymer hybrid nano-system: preparation, characterization, and anti myocardial infarction activity assessment

References

• Agbo E, Liu D, Li M, et al. (2019). Modulation of PTEN by hexarelin attenuates coronary artery ligation-induced heart failure in rats. Turk J Med Sci 49:945–58.
   PubMed Web of Science ®Google Scholar
• Benjamin EJ, Muntner P, Alonso A, et al. (2019). Heart disease and stroke statistics-2019 update: a report from the American Heart Association. Circulation 139:e56–e528.
   PubMed Web of Science ®Google Scholar
• Benjamin EJ, Virani SS, Callaway CW, et al. (2018). Heart disease and stroke statistics-2018 update: a report from the American Heart Association. Circulation 137:e67–e492.
   PubMed Web of Science ®Google Scholar
• Birk AV, Liu S, Soong Y, et al. (2013). The mitochondrial-targeted compound SS-31 re-energizes ischemic mitochondria by interacting with cardiolipin. J Am Soc Nephrol 24:1250–61.
   PubMed Web of Science ®Google Scholar
• Bonora M, Wieckowski MR, Sinclair DA, et al. (2019). Targeting mitochondria for cardiovascular disorders: therapeutic potential and obstacles. Nat Rev Cardiol 16:33–55.
   PubMed Web of Science ®Google Scholar
• Campani V, Salzano G, Lusa S, De Rosa G. (2016). Lipid nanovectors to deliver RNA oligonucleotides in cancer. Nanomaterials (Basel) 6:131.
   PubMedGoogle Scholar
• Dhanasekaran S, Venugopal D, Al-Dayan N, et al. (2020). Emerging insights into mitochondria-specific targeting and drug delivering strategies: recent milestones and therapeutic implications. Saudi J Biol Sci 27:3581–92.
   PubMed Web of Science ®Google Scholar
• Dong Z, Guo J, Xing X, et al. (2017). RGD modified and PEGylated lipid nanoparticles loaded with puerarin: formulation, characterization and protective effects on acute myocardial ischemia model. Biomed Pharmacother 89:297–304.
   PubMed Web of Science ®Google Scholar
• Du J, Li L. (2016). Which one performs better for targeted lung cancer combination therapy: pre- or post-bombesin-decorated nanostructured lipid carriers? Drug Deliv 23:1799–809.
   PubMed Web of Science ®Google Scholar
• Fan X, Wang T, Ji Z, et al. (2021). Synergistic combination therapy of lung cancer using lipid-layered cisplatin and oridonin co-encapsulated nanoparticles. Biomed Pharmacother 141:111830.
   PubMed Web of Science ®Google Scholar
• Frangogiannis NG, Shimoni S, Chang SM, et al. (2002). Evidence for an active inflammatory process in the hibernating human myocardium. Am J Pathol 160:1425–33.
   PubMed Web of Science ®Google Scholar
• Gao H, Liu J, Yang C, et al. (2013). The impact of PEGylation patterns on the in vivo biodistribution of mixed shell micelles. Int J Nanomed 8:4229–46.
   PubMed Web of Science ®Google Scholar
• Gao J, Liu ZJ, Chen T, Zhao D. (2014). Pharmaceutical properties of calycosin, the major bioactive isoflavonoid in the dry root extract of Radix astragali. Pharm Biol 52:1217–22.
   PubMed Web of Science ®Google Scholar
• Gao Z, Li Z, Yan J, Wang P. (2017). Irinotecan and 5-fluorouracil-co-loaded, hyaluronic acid-modified layer-by-layer nanoparticles for targeted gastric carcinoma therapy. Drug Des Devel Ther 11:2595–604.
   PubMed Web of Science ®Google Scholar
• Guo J, Xing X, Lv N, et al. (2019). Therapy for myocardial infarction: in vitro and in vivo evaluation of puerarin-prodrug and tanshinone co-loaded lipid nanoparticulate system. Biomed Pharmacother 120:109480.
   PubMed Web of Science ®Google Scholar
• Guo S, Zhang Y, Wu Z, et al. (2019). Synergistic combination therapy of lung cancer: cetuximab functionalized nanostructured lipid carriers for the co-delivery of paclitaxel and 5-Demethylnobiletin. Biomed Pharmacother 118:109225.
   PubMed Web of Science ®Google Scholar
• He Q, Zhang Z, Gao F, et al. (2011). In vivo biodistribution and urinary excretion of mesoporous silica nanoparticles: effects of particle size and PEGylation. Small 7:271–80.
   PubMed Web of Science ®Google Scholar
• Jian X, Li S, Feng Y, et al. (2020). Influence of synthesis methods on the high-efficiency removal of Cr(VI) from aqueous solution by Fe-modified magnetic biochars. ACS Omega 5:31234–43.
   PubMed Web of Science ®Google Scholar
• Jiang T, Ma S, Shen Y, et al. (2021). Topical anesthetic and pain relief using penetration enhancer and transcriptional transactivator peptide multi-decorated nanostructured lipid carriers. Drug Deliv 28:478–86.
   PubMed Web of Science ®Google Scholar
• Keeley EC, Weaver WD. (1999). Combination therapy for acute myocardial infarction. J Am Coll Cardiol 34:1963–5.
   PubMedGoogle Scholar
• Kuang X, Zhou S, Guo W, et al. (2017). SS-31 peptide enables mitochondrial targeting drug delivery: a promising therapeutic alteration to prevent hair cell damage from aminoglycosides. Drug Deliv 24:1750–61.
   PubMed Web of Science ®Google Scholar
• Li D, Cui R, Xu S, Liu Y. (2020). Synergism of cisplatin-oleanolic acid co-loaded hybrid nanoparticles on gastric carcinoma cells for enhanced apoptosis and reversed multidrug resistance. Drug Deliv 27:191–9.
   PubMed Web of Science ®Google Scholar
• Li S, Wang L, Li N, et al. (2017). Combination lung cancer chemotherapy: design of a pH-sensitive transferrin-PEG-Hz-lipid conjugate for the co-delivery of docetaxel and baicalin. Biomed Pharmacother 95:548–55.
   PubMed Web of Science ®Google Scholar
• Li W, Wu J, Zhang J, et al. (2018). Puerarin-loaded PEG-PE micelles with enhanced anti-apoptotic effect and better pharmacokinetic profile. Drug Deliv 25:827–37.
   PubMed Web of Science ®Google Scholar
• Li WQ, Wu JY, Xiang DX, et al. (2019). Micelles loaded with puerarin and modified with triphenylphosphonium cation possess mitochondrial targeting and demonstrate enhanced protective effect against isoprenaline-induced H9c2 cells apoptosis. Int J Nanomed 14:8345–60.
   PubMed Web of Science ®Google Scholar
• Liu J, Cheng H, Han L, et al. (2018). Synergistic combination therapy of lung cancer using paclitaxel- and triptolide-coloaded lipid-polymer hybrid nanoparticles. Drug Des Devel Ther 12:3199–209.
   PubMed Web of Science ®Google Scholar
• Liu L, Leng J, Yang X, et al. (2016). Rapid screening and identification of BSA bound ligands from radix astragali using BSA immobilized magnetic nanoparticles coupled with HPLC-MS. Molecules 21:1471.
   PubMed Web of Science ®Google Scholar
• Lukyanov AN, Hartner WC, Torchilin VP. (2004). Increased accumulation of PEG-PE micelles in the area of experimental myocardial infarction in rabbits. J Control Release 94:187–93.
   PubMed Web of Science ®Google Scholar
• Mendez-Fernandez A, Cabrera-Fuentes HA, Velmurugan B, et al. (2020). Nanoparticle delivery of cardioprotective therapies. Cond Med 3:18–30.
   PubMedGoogle Scholar
• Miyamoto S, Zhang G, Hall D, et al. (2020). Restoring mitochondrial superoxide levels with elamipretide (MTP-131) protects db/db mice against progression of diabetic kidney disease. J Biol Chem 295:7249–60.
   PubMed Web of Science ®Google Scholar
• Ou LC, Zhong S, Ou JS, Tian JW. (2021). Application of targeted therapy strategies with nanomedicine delivery for atherosclerosis. Acta Pharmacol Sin 42:10–7.
   PubMed Web of Science ®Google Scholar
• Pawar H, Surapaneni SK, Tikoo K, et al. (2016). Folic acid functionalized long-circulating co-encapsulated docetaxel and curcumin solid lipid nanoparticles: in vitro evaluation, pharmacokinetic and biodistribution in rats. Drug Deliv 23:1453–68.
   PubMed Web of Science ®Google Scholar
• Peeters L, Sanders NN, Jones A, et al. (2007). Post-pegylated lipoplexes are promising vehicles for gene delivery in RPE cells. J Control Release 121:208–17.
   PubMed Web of Science ®Google Scholar
• Qiu J, Cai G, Liu X, Ma D. (2017). αvβ3 integrin receptor specific peptide modified, salvianolic acid B and panax notoginsenoside loaded nanomedicine for the combination therapy of acute myocardial ischemia. Biomed Pharmacother 96:1418–26.
   PubMed Web of Science ®Google Scholar
• Ramachandra CJA, Hernandez-Resendiz S, Crespo-Avilan GE, et al. (2020). Mitochondria in acute myocardial infarction and cardioprotection. EBioMedicine 57:102884.
   PubMed Web of Science ®Google Scholar
• Reed GW, Rossi JE, Cannon CP. (2017). Acute myocardial infarction. Lancet 389:197–210.
   PubMed Web of Science ®Google Scholar
• Shao M, Yang W, Han G. (2017). Protective effects on myocardial infarction model: delivery of schisandrin B using matrix metalloproteinase-sensitive peptide-modified, PEGylated lipid nanoparticles. Int J Nanomed 12:7121–30.
   PubMed Web of Science ®Google Scholar
• Sims LB, Curry KC, Parupalli S, et al. (2019). Efficacy of surface-modified PLGA nanoparticles as a function of cervical cancer type. Pharm Res 36:66.
   PubMed Web of Science ®Google Scholar
• Suk JS, Xu Q, Kim N, et al. (2016). PEGylation as a strategy for improving nanoparticle-based drug and gene delivery. Adv Drug Deliv Rev 99:28–51.
   PubMed Web of Science ®Google Scholar
• Wang Z, Wei Y, Fang G, et al. (2018). Colorectal cancer combination therapy using drug and gene co-delivered, targeted poly(ethylene glycol)-ε-poly(caprolactone) nanocarriers. Drug Des Devel Ther 12:3171–80.
   PubMed Web of Science ®Google Scholar
• Yang F, Li A, Liu H, Zhang H. (2018). Gastric cancer combination therapy: synthesis of a hyaluronic acid and cisplatin containing lipid prodrug coloaded with sorafenib in a nanoparticulate system to exhibit enhanced anticancer efficacy and reduced toxicity. Drug Des Devel Ther 12:3321–33.
   PubMed Web of Science ®Google Scholar
• Yao C, Shi X, Lin X, et al. (2015). Increased cardiac distribution of mono-PEGylated Radix Ophiopogonis polysaccharide in both myocardial infarction and ischemia/reperfusion rats. Int J Nanomed 10:409–18.
   PubMed Web of Science ®Google Scholar
• Yu J, Li W, Yu D. (2018). Atrial natriuretic peptide modified oleate adenosine prodrug lipid nanocarriers for the treatment of myocardial infarction: in vitro and in vivo evaluation. Drug Des Devel Ther 12:1697–706.
   PubMed Web of Science ®Google Scholar
• Zhang S, Li J, Hu S, et al. (2018). Triphenylphosphonium and D-α-tocopheryl polyethylene glycol 1000 succinate-modified, tanshinone IIA-loaded lipid-polymeric nanocarriers for the targeted therapy of myocardial infarction. Int J Nanomed 13:4045–57.
   PubMed Web of Science ®Google Scholar
• Zhang S, Wang J, Pan J. (2016). Baicalin-loaded PEGylated lipid nanoparticles: characterization, pharmacokinetics, and protective effects on acute myocardial ischemia in rats. Drug Deliv 23:3696–703.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Wu J, Guo S, et al. (2019). The clinical efficacy and safety of the Chinese herbal medicine Astragalus (Huangqi) preparation for the treatment of acute myocardial infarction: a systematic review of randomized controlled trials. Medicine (Baltimore) 98:e15256.
   PubMedGoogle Scholar
• Zhao K, Zhao GM, Wu D, et al. (2004). Cell-permeable peptide antioxidants targeted to inner mitochondrial membrane inhibit mitochondrial swelling, oxidative cell death, and reperfusion injury. J Biol Chem 279:34682–90.
   PubMed Web of Science ®Google Scholar